Holdings

Affinity Asset Advisors, LLC

As of Sep 30, 2026, Affinity Asset Advisors, LLC reported 97 positions worth US$1.6B. Largest: Roivant Sciences Ltd., Spyre Therapeutics, Inc. and Erasca, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Roivant Sciences Ltd.3.2MUS$117M−550KSep 30, 2026
Spyre Therapeutics, Inc.1.28MUS$114Mno changeSep 30, 2026
Erasca, Inc.5.59MUS$82M+341KSep 30, 2026
First Tracks Biotherapeutics, Inc.2.08MUS$73.7M+47,988Sep 30, 2026
Xenon Pharmaceuticals Inc.1.9MUS$70.7M+305KSep 30, 2026
Insmed Incorporated564KUS$64.4M−85,749Sep 30, 2026
Oruka Therapeutics, Inc.600KUS$50M+10,000Sep 30, 2026
Avalo Therapeutics, Inc.3.24MUS$49.7M+345KSep 30, 2026
Cytokinetics, Incorporated750KUS$49.4M+200KSep 30, 2026
Revolution Medicines, Inc.225KUS$46.2M−25,000Sep 30, 2026